Addus HomeCare Co. (NASDAQ:ADUS – Get Free Report) EVP Michael D. Wattenbarger sold 750 shares of the business’s stock in a transaction on Monday, August 7th. The stock was sold at an average price of $93.96, for a total transaction of $70,470.00. Following the transaction, the executive vice president now directly owns 6,222 shares in the company, valued at approximately $584,619.12. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Addus HomeCare Trading Up 1.2 %
Shares of ADUS stock opened at $95.62 on Thursday. The company has a market capitalization of $1.55 billion, a P/E ratio of 28.89, a P/E/G ratio of 1.99 and a beta of 0.85. Addus HomeCare Co. has a 12-month low of $77.30 and a 12-month high of $114.99. The company has a quick ratio of 1.55, a current ratio of 1.55 and a debt-to-equity ratio of 0.12. The firm has a 50-day moving average price of $91.66 and a 200 day moving average price of $97.86.
Analyst Upgrades and Downgrades
Several equities analysts have commented on ADUS shares. Stephens upped their price target on Addus HomeCare from $100.00 to $110.00 and gave the company an “overweight” rating in a report on Wednesday, August 2nd. Raymond James raised their target price on Addus HomeCare from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 2nd. StockNews.com cut shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 20th. Oppenheimer reiterated an “outperform” rating and set a $118.00 target price on shares of Addus HomeCare in a research report on Wednesday, August 2nd. Finally, Royal Bank of Canada dropped their price target on shares of Addus HomeCare from $123.00 to $109.00 in a research report on Wednesday, May 3rd. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat, Addus HomeCare has an average rating of “Buy” and a consensus target price of $110.50.
Institutional Inflows and Outflows
A number of institutional investors have recently modified their holdings of ADUS. Morgan Stanley increased its position in Addus HomeCare by 744.6% in the 4th quarter. Morgan Stanley now owns 907,193 shares of the company’s stock valued at $90,257,000 after acquiring an additional 799,785 shares in the last quarter. Eaton Vance Management increased its holdings in shares of Addus HomeCare by 20.9% in the first quarter. Eaton Vance Management now owns 754,080 shares of the company’s stock valued at $70,348,000 after purchasing an additional 130,469 shares in the last quarter. Great Lakes Advisors LLC bought a new position in Addus HomeCare in the 1st quarter worth approximately $5,556,000. Tributary Capital Management LLC lifted its holdings in Addus HomeCare by 43.8% during the 2nd quarter. Tributary Capital Management LLC now owns 166,949 shares of the company’s stock worth $15,476,000 after buying an additional 50,891 shares in the last quarter. Finally, Avalon Investment & Advisory bought a new position in Addus HomeCare in the 1st quarter valued at $3,782,000. Institutional investors own 96.42% of the company’s stock.
About Addus HomeCare
Addus HomeCare Corp. engages in the provision of in-home personal care services. It operates through the following segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled.
Featured Stories
- Five stocks we like better than Addus HomeCare
- Bank Stocks – Best Bank Stocks to Invest In
- 3 Best Renewable Energy Stocks as Summer Heat Builds
- Pros And Cons Of Monthly Dividend Stocks
- Kinder Morgan Shines With Dividend Yield, Cash Flow, Buybacks
- Stock Dividend Cuts Happen Are You Ready?
- 3 Stocks to Buy No Matter Which Way Inflation Moves
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.